. 2022 Oct 28;12(5):5688–5702. doi: 10.1002/cam4.5311
© 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
FIGURE 5.
ML385 inhibits recruitment of mTOR to the lysosome.